| Term 
 
        | zolpidem (Ambien, Ambien CR) |  | Definition 
 
        | Classification: Sedative/hypnotic   Indications: Insomnia   Action: Sedation and induction of sleep   Major Adverse Side Effects: NVD, anaphylactic reactions, hallucinations.   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antidepressant   Indications: Depression   Action: Potentiates the effect of serotonin and norepinephrine in the CNS   Major Adverse Side Effects: arrhythmias, hypotension, constipation, sedation   Routes: PO, IM |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Mood Stabilizer   Indications: Manic episodes of manic depressive illness   Action: Prevents/decreases incidence of acute manic episodes   Major Adverse Side Effects: Seizures, impaired memory, arrhythmias, muscle weakness, hypothyroidism    Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Antipsychotic, mood stabilizer   Indications: psychotic disorders: including bipolar disorder, treatment of schizophrenia   Action: Decreases manifestations of psychoses   Major Adverse Side Effects: neuroleptic malignant syndrome, seizures, sedation, tachycardia   Routes: PO, IM |  | 
        |  | 
        
        | Term 
 
        | trazodone (Desyrel, Trialodine, Trazon) |  | Definition 
 
        | Classification: antidepressant   Indications: Major depression   Action: Alters the effects of serotonin in tht CNS   Major Adverse Side Effects: drowsiness, hypotension arrhythmias   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Antidepressant, MAO inhibitor   Indications: Depression in patients who have failed other drug therapies   Action: improved mood in depressed patients   Major Adverse Side Effects: seizures, hypertensive crysis,  arrhythmias   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | venlafaxine (Effexor, XR) |  | Definition 
 
        | Classification: antidepressant, antianxiety agent   Indications: Major depressive illness or relapse, in conjunction with psychotherapy, social and general anxiety   Action: decreases anxiety   Major Adverse Side Effects: seizures, abnormal dreams, anxiety, insomnia   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antipsychotic   Indications: acute and chronic psychotic desorders including schizophrenia, manic states, drug-induced psychoses   Action:  diminishes SSx of psychoses   Major Adverse Side Effects: seizures, neuroleptic malignant syndrome, extrapyramidal reactions   Routes: PO, IM |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Anitdepressant, SSRI   Indications: Major depressive disorders, panic disorder   Action: Antidepressant action   Major Adverse Side Effects: tremor, sexual dysfunction, insomnia, diarrhea   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: anti-Alzheimer's agent, cholinergic   Indications: Mild to moderate dementia associated with Alzheimer's disease   Action: Decreases dementia associatede w/ Alzheimer's and Parkinson's disease.   Major Adverse Side Effects: weakness, anorexia, NVD   Routes: PO, transdermal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antiarrythmics, anticonvulsants   Indications: Treatment/prevention of tonic-clonic seizures and complex partial seizures   Action: Diminished seizure activity   Major Adverse Side Effects: Stevens-Johnsons syndrome, agranulocytosis, aplastic anemia   Routes: PO, IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Anesthetic   Indications: General anesthesia during dental procedures   Action: dulls pain during surgical procedures   Major Adverse Side Effects:   Routes: Aerosol  |  | 
        |  | 
        
        | Term 
 
        | lovaststin (Altoprev, Mevacor) |  | Definition 
 
        | Classification: lipid lowering agent, HMG-CoA reductase inhibitor   Indications: Primary prevention of CHD   Action: Lowers total and LDL cholesterol and triglycerides   Major Adverse Side Effects: rhabdomyolysis, abdominal cramps, constipation   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | ezetimibe (Ezetrol, Zetia) |  | Definition 
 
        | Classification: lipid lowering agent   Indications: Managment of dyslipidemias, including hypercholesterolemia   Action: lowering of cholesterol, a risk factor for atherosclerosis   Major Adverse Side Effects: angioedema, pancreatitis   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | cholestyramine (Prevalite, Questran/light) |  | Definition 
 
        | Classification: lipid lowering agent   Indications: Managment of primary hypercholsterolemia   Action:decreases plasma cholesterol and LDLs   Major Adverse Side Effects: abdominal discomfort, constipation, vitamin A, D, K deficiency   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: anticonvulsant   Indications: absent seizures   Action: reduces the frequency of absent seizures   Major Adverse Side Effects: Stevens-Johnson syndrome, agranulocytosis, aplastic anemia, depression, seizures   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | propofol (Diprivan, Disoprofol) |  | Definition 
 
        | Classification: General anesthetic   Indications: general anesthesia, maintenance of balanced anesthesia   Action: induction and maintenance of anesthesia   Major Adverse Side Effects: apnea, bradycardia, hypotension   Routes: IV |  | 
        |  | 
        
        | Term 
 
        | fenofibrate (Tricor, Antara) |  | Definition 
 
        | Classification: lipid lowering agent   Indications: used w/ dietary therapy to decrease LDL cholesterol, total cholesterol, triglycerides in adults hypercholesterolemia or dyslipidemia   Action: lowers cholsterol and triglycerides w subsequent decrease risk of pancreatitis   Major Adverse Side Effects: fatique weakness, pancreatitis   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: water soluble vitamins, lipid lowering agents   Indications: treatment anf prevention of niacin deficiency   Action: decreases blood lipids   Major Adverse Side Effects: hepatotoxicity, GI upset pruritus   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | amiodarone (Cordarone, Pacerone)  |  | Definition 
 
        | Classification: antiarrythmias   Indications: life threatening ventricular arrhythmias unresponsive to less toxic agents   Action: suppression of arrythmias   Major Adverse Side Effects: Adult respiratory distress syndrome, pulmonary fibrosis, pulmonary toxicity, CHF, liver function abnormalities, toxic epidermal necrolysis   Routes: PO, IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Anesthetics-local/topical   Indications: ventricular arrythmias and pain   Action: cotrol of ventricular arrythmias and local anesthetic   Major Adverse Side Effects: seizures, cardiac arrest, anaphylazis    Routes: IM, IV, topical/local |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: neuromuscular blocker   Indications: anesthesia adjunct, used for intubation and mechanical ventilation   Action: neuromuscular blockade   Major Adverse Side Effects: anaphylaxis, prolonged uscular block, bronchospasms   Routes: IV |  | 
        |  | 
        
        | Term 
 
        | Carbidopa-levodopa (Parcopa, Sinemet) |  | Definition 
 
        | Classification: antiparkinson agent   Indications: used for Parkinson's Disease   Action: Relief of tremors and rigidity in Parkinson's Syndrome   Major Adverse Side Effects: involuntary movements, NV   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: immune supressant, CNS agent   Indications: relapsing remitting multiple sclerosis   Action: modifies immune processes or functions which are thought to be liable for MS pathogenesis   Major Adverse Side Effects: eosinophilia, anaphaylaxis, dyspnea, diplopia   Routes: SQ |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: CNS agent, Glutamine antagonist   Indications: Amyotrophic lateral sclerosis   Action: inhibits glutamine release   Major Adverse Side Effects: cardiac arrest, neutropenia   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: stimulant   Indications: headache, somnolence   Action:    Major Adverse Side Effects: cardiac dysrythmia, tachyarryhtmia CNS stuimulation   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | dextroamphetamine (Dexedrine, Dextrostat) |  | Definition 
 
        | Classification: CNS Stimulant, amphetamine   Indications: Narcolepsy   Action: Increase motor activity and mental alertness and decreases fatigue in narcolepsy patients   Major Adverse Side Effects: hyperactivity, insomnia, tachycardia, palpitiations, anorexia   Routes: PO |  | 
        |  | 
        
        | Term 
 
        | methylphenidate (Ritalin) |  | Definition 
 
        | Classification: CNS stimulant   Indications: treatment of ADHD, treatment of narcolepsy   Action: Increased attention span in ADHD, increase motor activity, mental alertness   Major Adverse Side Effects: hyperactivity, insomnia, tachycardia, tremors, anorexia, palpitations   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Antidote (opioid)   Indications: reversal of CNS depression and respiratory depression because od opioid overdose   Action: reversal of signs of opioid excess   Major Adverse Side Effects: hypertension, hypotension, ventricular tachycardia/fibrillation   Routes: IV, IM |  | 
        |  | 
        
        | Term 
 
        | morphine sulfate (Duramorph) |  | Definition 
 
        | Classification:opioid analgesic   Indications: severe pain, pulmonary edema   Action: decreases in severity of pain   Major Adverse Side Effects: respiratory depression, sedation, hypotension, constipation   Routes: PO, IM, IV, Epidural, SQ,   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antipyretics, NSAID   Indications: inflammatory disorders, mild to moderate pain   Action: analgesia. reduction of inflammation, reduction of fever   Major Adverse Side Effects: GI bleeding, Stevens-Johnson Syndrome, epidermal necrolysis, anaphylaxis   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antipyretics, NSAID   Indications: mild to moderate pain, inflammatory disorders,  lowering of fever   Action: decreased pain and inflammation, reduction of fever   Major Adverse Side Effects: GI bleeding, hepatitis, Stevens-Johnson Syndrome, anaphylaxis   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antipyretics, NSAID   Indications: mild to moderate pain, inflammatory disorders,  lowering of fever   Action: decreased pain and inflammation, reduction of fever   Major Adverse Side Effects: GI bleeding, hepatitis, anaphylaxis   Routes: PO |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: Vascular headache suppressant   Indications: Acute treatment of migraine attacks   Action: Relief of acute attacks of migraine   Major Adverse Side Effects: vertigo, injection site reaction, MI   Routes: PO, SQ, Nasal |  | 
        |  | 
        
        | Term 
 
        | methotrexate (Folex, Trexall, Rheumatrex) |  | Definition 
 
        | Classification: Antineoplastic, antirheumatoics, immunosuppressant   Indications: treatment of severe psoriasis anf rheumatoid arthritis unresponsive to convential therapy   Action: death of rapidly replicating cells, particulary malignant ones and immunosuppression   Major Adverse Side Effects: arachnoiditisaplastic enemia, pulmonary fibrosis   Routes: PO, IV, IM |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antigout agent   Indications: acute attacks of gouty arthritis, prevention of the recurrance of gout   Action: decreased pain and inflammation in acute attacks of gout   Major Adverse Side Effects: agranulocytosis, aplastic anemia, NVD   Routes: PO, IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antigout agent   Indications: prevention of attack of gouty arthritis and nephropathy   Action: lowering of serum uric acid levels   Major Adverse Side Effects: rash, hepatitis, renal failure, hematuria, bone marrow depression   Routes: PO, IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Classification: antirheumatics   Indications: decrease the progression and SSx of rheumatoid arthritis   Action: decreased inflammation and slowed progression of arthritis   Major Adverse Side Effects: infections, upper respiratory tract infection   Routes: SQ |  | 
        |  |